Teladoc (TDOC, $169.27) shares drop, on analysts' price target cuts
Online healthcare company Teladoc Health’s shares fell Thursday as several analysts lowered their share-price targets – following lower-than-expected quarterly earnings.
Teladoc reported a loss of -$1.31 a share, steeper than the -40 cents loss expected by analysts. It is also wider than the year-ago quarter’s -40 cents per share.
Evercore ISI’s Elizabeth Anderson slashed her price target to $185 from $195 and kept her in-line rating. While she viewed the membership forecast and lower guidance for EBITDA in the second half of 2021, on rising expenses as negatives, she saw tailwinds in the increased revenue outlook, including the combined sales pipeline and TDOC’s specialty and mental health traction.
Citi analyst Daniel Grosslight lowered his price target on Teladoc shares to $260 from $275, but maintained his buy rating. “By most metrics, TDOC’s quarter was solid,” he said, but added that Teladoc faces “greater competitive intensity.”
Cowen analyst Charles Rhyee cut his price target to $240 from $268, while keeping his outperform rating. According to Rhyee, earnings were strong, but investors expected more and were disappointed visit gains “didn’t flow through to revenue.”
TDOC sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for TDOC moved above the 200-day moving average on June 25, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 16, 2026. You may want to consider a long position or call options on TDOC as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for TDOC just turned positive on June 17, 2026. Looking at past instances where TDOC's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TDOC advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 166 cases where TDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for TDOC moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
TDOC broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.225) is normal, around the industry mean (7.813). TDOC has a moderately low P/E Ratio (0.000) as compared to the industry average of (53.848). TDOC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.280). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (0.640) is also within normal values, averaging (6.086).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TDOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TDOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a telephone and online video consultation service
Industry ServicestotheHealthIndustry
Advertisement